NDC 17856-1133 – Spironolactone

Spironolactone 25 mg/5mL · Suspension · Oral

Human Prescription Drug

Product NDC17856-1133

Product details

Brand name
Spironolactone
Generic name
Spironolactone
Labeler
ATLANTIC BIOLOGICALS CORP.
Dosage form
Suspension
Route
Oral
Marketing category
NDA AUTHORIZED GENERIC · NDA209478
Marketed since
October 31, 2023
Listing expires
December 31, 2027
Pharmacologic class
Aldosterone Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Spironolactone →

Package NDC codes (6)

Package NDCDescriptionSince
17856-1133-11 SYRINGE in 1 BAG (17856-1133-1) / 2.5 mL in 1 SYRINGE (17856-1133-3)Jun 3, 2024
17856-1133-41 SYRINGE in 1 BAG (17856-1133-4) / 2.5 mL in 1 SYRINGE (17856-1133-2)Sep 26, 2025
17856-1133-5120 SYRINGE in 1 CASE (17856-1133-5) / 1 mL in 1 SYRINGEApr 30, 2026
17856-1133-6120 SYRINGE in 1 CASE (17856-1133-6) / 3 mL in 1 SYRINGEApr 30, 2026
17856-1133-71 SYRINGE in 1 BAG (17856-1133-7) / 1 mL in 1 SYRINGEJul 2, 2026
17856-1133-81 SYRINGE in 1 BAG (17856-1133-8) / 3 mL in 1 SYRINGEJul 2, 2026

Other Spironolactone products